Rapport Therapeutics (RAPP) Return on Assets (2024 - 2026)

Rapport Therapeutics (RAPP) has 3 years of Return on Assets data on file, last reported at 0.01% in Q1 2026.

• On a quarterly basis, Return on Assets rose 39.0% year-over-year to 0.01% in Q1 2026; TTM through Mar 2026 was 0.01%, a 39.0% increase from a year earlier, with the FY2025 full-year figure at 0.01%, changed 0.0% from the prior year.
• Return on Assets for Q1 2026 stood at 0.01%, up from 0.24% in the prior quarter.
• Over the last five years, Return on Assets for RAPP reached as high as 0.0% in Q3 2024 and fell as low as 0.42% in Q2 2025.
• Historically, Return on Assets has averaged 0.2% across 3 years, with a median of 0.24% in 2025.
• Across the five-year window, Return on Assets fell 30 bps in 2025 and soared 39 bps in 2026, its largest moves.
• Year by year, Return on Assets stood at 0.0% in 2024, then sank by 10803 bps to 0.24% in 2025, then surged by 96 bps to 0.01% in 2026.
• Per Business Quant data, the three most recent Return on Assets figures were 0.01% in Q1 2026, 0.24% in Q4 2025, and 0.3% in Q3 2025.